舒血宁对老年缺血性脑卒中疗效及生活质量的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Researches of Shuxuening on the Clinical Effects and Quality of Life in Old Patients with Ischemic Stoke
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的探讨舒血宁对老年缺血性脑卒中患者临床疗效和生活质量的影响。方法212例老年缺血性脑卒中患者随机分为治疗组和对照组各106例,两组均予常规治疗,治疗组加用舒血宁,对照组加用安慰剂,2周为一疗程。进行神经功能缺损评分,采用SS-QOL量表对患者进行生活质量问卷评价,检测血中内皮素1和降钙素基因相关肽。 结果治疗组总有效率为86.8%,明显高于对照组的76.5%(p<0.05);治疗后,治疗组SS-QOL量表评分明显提高,内皮素1含量下降,降钙素基因相关肽含量上升,与对照组差异有显著性(p<0.05或p<0.01)。 结论舒血宁结合常规治疗可明显改善老年缺血性脑卒中患者神经功能缺损评分,提高患者生活质量。

    Abstract:

    AimTo observe the impact of Shuxuening on the clinical effects and quality of life in old patients with ischemic stoke.Methods212 old patients with ischemic stroke were randomly divided into study group and control group.The control group was treated with conventional therapy; the study group was treated with Shuxuening additionally.All were treated for 2 weeks.The nerve function deficit score was evaluated, SS-QOL table was used to evaluate the quality of life in patients, the level of endothelin-1 (ET-1) and calcitonin gene related peptide(CGRP) were recorded.ResultsAfter treatment, the clinical efficiency were 86.8% in study group and 76.5% in control one(p<0.05); for the study group, the score of SS-QOL and CGRP increased greatly,ET-1 decreased greatly, and there were significant difference between the two groups (p<0.05 or p<0.01).ConclusionCombined with conventional therap, Shuxuening could improve the nerve function deficit score and quality of life in old patients with ischemic stoke.

    参考文献
    相似文献
    引证文献
引用本文

王明盛,林建英.舒血宁对老年缺血性脑卒中疗效及生活质量的影响[J].中国动脉硬化杂志,2012,20(10):923~926.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2012-06-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: